Skip to content

Apostel VI - Will a cervical pessary prolong pregnancy in women after an episode of threatened preterm labor.

Apostel VI - Will a cervical pessary prolong pregnancy in women after an episode of threatened preterm labor: a randomized trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28719
Enrollment
200
Registered
2013-10-16
Start date
2013-10-16
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy, Preterm birth, Threatened preterm labor, Pessary

Interventions

Eligible women will be randomly allocated to receive either a cervical pessary or no intervention. The cervical pessary will be placed in situ when undelivered, 48 hours after an episode of threatene

Sponsors

Academic Medical Center Amsterdam Meibergdreef 9 Postbus 22660 1100 DD Amsterdam The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -singleton/twin pregnancy -GA between 24+0 and 34+6 weeks - Cervical length >15mm-<30mm and positive fibronectin - undelivered after 48 hours

Exclusion criteria

Exclusion criteria: -major fetal abnormalities -signs of intra-uterine infection -ruptured membranes -cervical dilatation > 3cm -Residual cervical length that makes it impossible to place a pessary -randomisation >72 hours after becoming eligible

Design outcomes

Primary

MeasureTime frame
Preterm delivery <37 weeks of gestation.

Secondary

MeasureTime frame
Neonatal outcomes; composite of neonatal morbidity (e.g. RDS, BPD, IVH, NEC, PVL, sepsis) and death. Delivery outcomes: e.g. GA at delivery, time to delivery and preterm birth rates <34 and <32 weeks. Maternal outcomes: side-effects, complications of pessary

Contacts

Public ContactF.J.R. Hermans

Academic Medical Center Amsterdam, Meibergdreef 9

apostel6@studies-obsgyn.nl+31 (0) 20 566 4256

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)